Fervo Energy Company Class A common stock
FRVO
$12.87
-6.40%
Fervo Energy Company is a geothermal energy developer that builds, owns, and operates geothermal power facilities, generating revenue primarily through long-term power purchase agreements (PPAs) with utilities and other entities. The company distinguishes itself through proprietary innovations in computational modeling, horizontal drilling, and distributed fiber optic sensing, positioning it as a technology-driven disruptor in the traditionally capital-intensive renewable utilities space. The current investor narrative centers on Fervo's May 2026 IPO and its ability to commercialize next-generation geothermal technology at scale, with the stock experiencing extreme post-IPO volatility as the market digests its pre-revenue growth profile against a backdrop of significant cash burn. Recent analyst actions have been notably bullish, with multiple firms initiating coverage at Outperform or Buy ratings in September 2026, even as the share price has collapsed dramatically from its post-IPO highs, creating a sharp divergence between fundamental optimism and market pricing.…
FRVO
Fervo Energy Company Class A common stock
$12.87
Related headlines
Investment Opinion: Should I buy FRVO Today?
The synthesized recommendation is Hold, with a speculative bias. The core thesis is that FRVO's Strong Buy analyst consensus (14 analysts, mean 1.29) and average target price of $38.36 imply massive upside, but the company's pre-revenue status, -510.98% net margin, and -$261.22 million quarterly free cash flow present extreme execution risk that justifies caution. The stock is a binary bet on geothermal commercialization, suitable only for risk-tolerant investors with a long time horizon.
Supporting evidence for a Hold includes: 1) the primary valuation metric, PS ratio of 55,479x, is meaningless due to near-zero revenue, but the forward PS based on $763.7 million estimated revenue would be approximately 10x, still a premium to the sector's 2-4x; 2) revenue grew 85% sequentially to $113,000, but from a negligible base; 3) profitability is deeply negative with a -3.91% gross margin and -353.67% operating margin, far worse than sector norms of 15-30% net margins; 4) free cash flow is -$261.22 million, and the company has $2.11 billion in cash, providing a runway but requiring continued capital raises; 5) the implied upside to the analyst average target is +179%, but the low target of $25.00 still implies +82% upside, suggesting analysts see value even in a bear case. The wide target range ($25-$51) reflects high uncertainty.
The biggest risks that could invalidate the thesis are: 1) failure to achieve the $763.7 million forward revenue estimate, which would likely cause a break below the 52-week low of $13.10; 2) continued cash burn requiring dilutive financing, as evidenced by the $2.05 billion equity raise; and 3) competitive or regulatory headwinds that delay project timelines. The rating would upgrade to Buy if the company demonstrates consistent revenue growth (e.g., quarterly revenue exceeding $10 million) and a clear path to positive gross margins, or if the stock price stabilizes above $20 with improving relative strength. It would downgrade to Sell if revenue growth stalls, cash burn accelerates, or the stock breaks below $13.10 with no catalyst. Relative to its history and peers, FRVO is overvalued on current fundamentals but potentially undervalued if forward estimates are met; the market is pricing in a high-risk, high-reward scenario.
Sign up to view all
FRVO 12-Month Price Forecast
The forward-looking view is neutral with medium confidence, as the bull and bear cases are finely balanced. The bull case hinges on a successful revenue inflection to $763.7 million, which would justify the analyst target of $38.36, but the current quarterly run rate of $113,000 makes this a high-risk bet. The bear case is supported by the -510.98% net margin, -$261.22 million free cash flow, and the stock's 68.33% drawdown, which could continue if execution disappoints. Key factors to monitor include quarterly revenue growth, gross margin trends, and cash burn rate; an upgrade to bullish would require evidence of accelerating revenue and a clear path to profitability, while a downgrade to bearish would follow a break below $13.10 or a significant project delay. The wide analyst target range ($25-$51) and high short interest (2.51) suggest extreme volatility ahead, making position sizing critical.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Fervo Energy Company Class A common stock's 12-month outlook, with a consensus price target around $38.36 and implied upside of +198.0% versus the current price.
Average Target
$38.36
0 analysts
Implied Upside
+198.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$25 - $51
Analyst target range
Fervo is covered by 14 analysts, with a consensus recommendation of "Strong Buy" (recommendation mean of 1.29, where 1.0 is a Strong Buy and 5.0 is a Sell). The average target price is $38.36, which implies a staggering +179% upside from the current price of $13.75 — a disconnect that highlights either a massive mispricing opportunity or analyst estimates that have not yet been updated to reflect the recent price collapse. The consensus leans overwhelmingly bullish, with recent institutional actions showing a wave of upgrades and initiations: Wolfe Research upgraded to Outperform on September 25, 2026, Jefferies upgraded to Buy from Hold on July 20, 2026, and B of A Securities upgraded to Buy from Neutral on July 17, 2026. This pattern of upgrades into a declining stock price is unusual and suggests analysts are looking through near-term price weakness to a longer-term growth narrative.
The target price range spans from a low of $25.00 to a high of $51.00, a spread of $26.00 (or 104% of the low target), indicating significant disagreement among analysts about the company's prospects. The high target of $51.00 implies a market cap of roughly $15 billion and assumes successful execution on the forward revenue estimate of $763.7 million, multiple expansion as the company scales, and potentially new project announcements or PPA signings. The low target of $25.00 — still 82% above the current price — prices in slower-than-expected revenue ramp, continued cash burn requiring dilutive financing, and margin compression from higher-than-anticipated operating costs. The wide spread signals high uncertainty, which is typical for pre-revenue companies with binary outcomes. Notably, the estimated EPS average of $0.665 for the forward year, with a range of $0.48 to $0.76, implies the company is expected to achieve profitability within the next 12 months — a forecast that stands in stark contrast to the current quarterly loss of $0.20 per share and will require a dramatic operational inflection to materialize.
Bulls vs Bears: FRVO Investment Factors
The bear case currently has stronger evidence, as FRVO's -68% drawdown, -510.98% net margin, and -$261 million quarterly cash burn reflect a company in the pre-revenue phase with no near-term path to profitability. However, the bull case rests on a dramatic revenue inflection to $763.7 million and a Strong Buy consensus with a $38.36 average target, creating a sharp disconnect between analyst optimism and market pricing. The single most important tension is whether Fervo can successfully commercialize its geothermal technology at scale — if forward revenue materializes, the stock is deeply undervalued; if not, the valuation has virtually no support. The extreme volatility (68% peak-to-trough drawdown) and binary outcome warrant a speculative classification, with position sizing reflecting the high risk of permanent capital loss.
Bullish
- Analyst consensus Strong Buy with 179% upside: 14 analysts rate FRVO a Strong Buy (recommendation mean 1.29), with an average target price of $38.36 versus the current $13.75 — implying +179% upside. Recent upgrades from Wolfe Research (Outperform, Sep 25, 2026), Jefferies (Buy, Jul 20, 2026), and B of A (Buy, Jul 17, 2026) suggest institutional conviction remains intact despite the price collapse.
- Massive forward revenue inflection expected: Analysts project forward revenue of $763.7 million versus the current quarterly run rate of just $113,000 — a 6,700x increase. This implies the market is pricing in successful commercialization of Fervo's geothermal technology, with estimated EPS of $0.665 next year versus the current quarterly loss of $0.20 per share.
- Strong liquidity with $2.11B cash: Following a $2.05 billion common stock issuance, Fervo holds $2.11 billion in cash, with a current ratio of 3.17 and quick ratio of 8.62. This provides a multi-year runway to fund its $226.5 million quarterly capex program without immediate financing risk, unlike many pre-revenue peers.
- Revenue growing 85% sequentially: Q2 2026 revenue of $113,000 rose 85% from Q1's $61,000, demonstrating early commercial traction. While the base is tiny, the sequential growth rate signals that Fervo's PPAs are beginning to generate electricity sales, validating its technology and business model.
Bearish
- Catastrophic price collapse of 68% from peak: FRVO has plummeted 68.33% from its post-IPO high of $42.65 to $13.75, trading just 2.2% above its 52-week low of $13.10. The 3-month decline of 49.32% and 1-month decline of 20.24% show accelerating selling pressure with no sign of stabilization.
- Deeply negative margins and cash burn: Q2 2026 net loss was $59.53 million on revenue of $113,000, a net margin of -510.98%. Gross margin is -3.91%, operating margin is -353.67%, and free cash flow was -$261.22 million, meaning the company spends over $5 for every $1 of revenue and burns cash at an alarming rate.
- Valuation completely detached from fundamentals: The trailing PS ratio of 55,479x and EV/Sales of 7,969.94 are astronomical compared to the renewable utilities sector average PS of 2-4x. With negative book value (PB ratio -31.06) and negative EBITDA (-$28.4 million), there is virtually no fundamental valuation support if growth disappoints.
- Severe underperformance versus S&P 500: FRVO has lagged the S&P 500 by 22.36 percentage points over the past month and 52.45 percentage points over the past three months, while SPY gained 2.12% and 3.13% respectively. This divergence — a falling stock in a rising market — signals company-specific distress or sector rotation away from speculative renewables.
FRVO Technical Analysis
FRVO is in a severe, sustained downtrend, having declined approximately 62% from its 52-week high of $42.65 to the current price of $13.75. The stock is trading at just 2.2% above its 52-week low of $13.10, placing it at the very bottom of its 52-week range — a positioning that signals either deep value or a falling knife, with the latter interpretation strongly favored given the persistent selling pressure. The 1-year price change of -5% masks the true severity of the decline, as the stock's brief post-IPO pop in May 2026 has been entirely erased and then some. The max drawdown of -68.33% from peak to trough underscores the brutal nature of this selloff and the absence of any meaningful support levels holding.
Short-term momentum is decisively negative and accelerating to the downside, with a 1-month price change of -20.24% and a 3-month change of -49.32%. This represents a clear deceleration from the already weak longer-term trend, as the pace of decline has intensified in recent months rather than stabilized. The relative strength metrics confirm this underperformance: FRVO has lagged the S&P 500 by 22.36 percentage points over the past month and by a staggering 52.45 percentage points over the past three months, while SPY gained 2.12% and 3.13% respectively over those same periods. This divergence — a falling stock in a rising market — is a classic signal of company-specific distress or sector rotation away from speculative renewable energy names, and the absence of any positive momentum inflection suggests sellers remain in control.
Key technical support is anchored at the 52-week low of $13.10, which is only $0.65 below the current price of $13.75 — a breakdown below this level would likely trigger a new leg lower with no historical price reference points to guide the downside. Resistance is established at the 52-week high of $42.65, but more immediately relevant is the $15-$16 zone where the stock consolidated briefly in late September 2026 before resuming its decline. The short ratio of 2.51 indicates that short sellers have accumulated a meaningful position relative to average daily volume, which could theoretically fuel a sharp short squeeze on any positive catalyst, but also reflects persistent bearish conviction. With a beta not available in the provided data, volatility must be inferred from the price action itself — a 68% peak-to-trough drawdown in under six months implies extremely high volatility, warranting conservative position sizing and wide stop-loss levels for any risk-managed entry.
Beta
—
—
Max Drawdown
-69.7%
Largest decline past year
52-Week Range
$13-$43
Price range past year
Annual Return
—
Cumulative gain past year
| Period | FRVO Return | S&P 500 |
|---|---|---|
| 1m | -17.4% | +1.8% |
| 3m | -48.6% | +3.5% |
| 6m | — | +11.2% |
| 1y | — | +19.1% |
| ytd | — | +14.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FRVO Fundamental Analysis
Fervo's revenue trajectory is nascent and deeply unprofitable, with Q2 2026 revenue of just $113,000 representing a sequential increase from Q1 2026's $61,000 — a 85% quarter-over-quarter gain but from a nearly nonexistent base. The company's gross profit was negative $537,000 in Q2 2026, meaning it costs more to deliver electricity than it generates in revenue, a reflection of the early-stage nature of its geothermal facilities and the fixed costs associated with operating them. With estimated forward revenue of approximately $763.7 million (analyst consensus average), the market is pricing in a dramatic inflection in the coming years, but the current quarterly run rate of roughly $0.1 million is orders of magnitude below that projection, highlighting the enormous execution risk embedded in the investment case.
Profitability remains deeply negative across all metrics, with Q2 2026 net income of -$59.53 million and a net margin of -510.98%, meaning the company spends over five dollars for every dollar of revenue generated. Gross margin stands at -3.91%, operating margin at -353.67%, and EBITDA at -$28.40 million for the quarter, all confirming that Fervo is in the capital-intensive pre-profitability phase typical of early-stage renewable energy developers. The Q2 net loss of $59.53 million widened from Q1's $35.26 million, a 69% sequential increase in losses, driven partly by a $27.17 million negative swing in total other income/expenses and rising SG&A costs of $28.92 million. While the negative gross margin is concerning, it is not atypical for a company in the construction and early operational phase of geothermal facilities, where depreciation and fixed costs are spread over minimal output.
The balance sheet presents a mixed picture: the current ratio of 3.17 and quick ratio of 8.62 indicate strong short-term liquidity, bolstered by $2.11 billion in cash at the end of Q2 2026 following a $2.05 billion common stock issuance. However, free cash flow was deeply negative at -$261.22 million in Q2 2026, driven by $226.49 million in capital expenditures, and operating cash flow was -$34.74 million, meaning the company is burning cash at an alarming rate even before accounting for its aggressive investment program. The debt-to-equity ratio of -1.02 (negative due to negative equity) and the debt ratio of 0.096 suggest that while debt levels are currently manageable relative to assets, the company's reliance on external financing — evidenced by the massive equity raise — is a significant risk if capital markets tighten. The ROE of 28.61% appears positive but is distorted by negative equity, and the interest coverage ratio of -12.98 confirms that operating earnings are insufficient to cover interest expenses, a red flag for financial sustainability without continued access to capital.
Quarterly Revenue
$113000.0B
2026-06
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FRVO Overvalued?
Because Fervo's trailing net income is negative (-$59.53 million in Q2 2026 alone) and EBITDA is also negative (-$28.40 million), the PE ratio is not meaningful and the PS ratio is the appropriate primary metric. The trailing PS ratio is an astronomical 55,479x, reflecting the near-zero revenue base of $113,000 in Q2 2026, while the forward PE of -50.39 (negative) and EV/Sales of 7,969.94 confirm that traditional valuation metrics are essentially meaningless at this stage. The gap between trailing and forward estimates — with analysts projecting $763.7 million in forward revenue versus the current $0.1 million quarterly run rate — implies the market is pricing in a near-term revenue explosion that has yet to materialize, creating a binary risk profile where execution either validates the valuation or leads to further multiple compression.
Comparing Fervo to the broader Renewable Utilities sector, the company's valuation multiples are extreme outliers: the PS ratio of 55,479x versus a typical utility sector PS of 2-4x represents a premium of over 1,000,000%, though this comparison is distorted by Fervo's pre-revenue status. More meaningful is the EV/EBITDA of -153.45, which is negative and therefore not comparable to sector averages, and the PB ratio of -31.06, which is negative due to negative book value. The premium embedded in Fervo's valuation is entirely predicated on future growth — analysts expect EPS of $0.665 next year — and if that growth fails to materialize, the stock has virtually no valuation support from current fundamentals. The negative gross margin of -3.91% and operating margin of -353.67% are far worse than sector norms, where established utilities typically operate at 15-30% net margins, underscoring the execution gap Fervo must close to justify any premium.
Historically, Fervo has only two quarters of public financial data, making historical valuation context limited. In Q1 2026, the PS ratio was 125,511x and the PB ratio was 10.28x; by Q2 2026, the PS ratio had fallen to 76,219x and the PB ratio to 3.08x, reflecting both the stock price decline and the slight increase in revenue. The current PS ratio of 55,479x (based on the most recent data) is below the Q1 and Q2 2026 historical averages, but this is primarily because the stock price has collapsed, not because revenue has grown meaningfully. The PB ratio of -31.06 is now negative, a deterioration from 3.08x in Q2 2026, signaling that the company's equity has been wiped out by accumulated losses. This trajectory — falling multiples driven by price declines rather than fundamental improvement — suggests the market is losing confidence in the growth story, and until revenue begins to scale meaningfully, the valuation will remain untethered from traditional anchors.
PE
-108.0x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-153.4x
Enterprise Value Multiple
Investment Risk Disclosure
Fervo's financial and operational risks are severe and quantifiable. The company generated just $113,000 in Q2 2026 revenue while incurring a net loss of $59.53 million, resulting in a net margin of -510.98% — meaning it spends over five dollars for every dollar of revenue. Free cash flow was -$261.22 million, driven by $226.49 million in capital expenditures, and operating cash flow was -$34.74 million, indicating that even before growth capex, the business consumes cash. With a debt-to-equity ratio of -1.02 (negative due to negative equity) and an interest coverage ratio of -12.98, the company relies entirely on external financing, evidenced by the $2.05 billion equity raise that boosted cash to $2.11 billion but also diluted shareholders by 294.65 million shares. The negative gross margin of -3.91% and operating margin of -353.67% highlight that fixed costs are spread over minimal output, and until revenue scales meaningfully, these losses will persist.
Market and competitive risks are amplified by FRVO's extreme valuation and speculative nature. The trailing PS ratio of 55,479x and EV/Sales of 7,969.94 are orders of magnitude above the renewable utilities sector average PS of 2-4x, leaving the stock vulnerable to severe multiple compression if growth expectations are not met. The stock has underperformed the S&P 500 by 52.45 percentage points over three months, and with a beta not provided, its volatility is evident from the 68.33% max drawdown in under six months. Competitive risks include the potential for other renewable energy sources (solar, wind) to achieve cost advantages, and regulatory headwinds if geothermal subsidies or permitting processes change. The recent news of a successful IPO and first-day dip is typical, but the subsequent 68% decline suggests the market is questioning the commercialization timeline, and any delay in PPA signings or project completions could trigger further selling.
The worst-case scenario for FRVO involves a chain of events where the company fails to scale revenue, leading to continued cash burn that exhausts its $2.11 billion cash reserve faster than expected. If forward revenue estimates of $763.7 million are not achieved, the stock could break below its 52-week low of $13.10, with the next support level unknown given the lack of historical price data. The analyst low target of $25.00 is still 82% above the current price, but in a bear case, the stock could retest its IPO price or lower; a drop to $10 would represent a 27% loss from the current $13.75, and a decline to $5 would be a 64% loss. Given the negative book value and no dividend, the downside is substantial, and investors could lose a significant portion of their capital if the growth story fails to materialize.
FAQ
The key risks are ranked by severity: 1) Financial risk — the company has a -510.98% net margin and burns $261.22 million in free cash flow per quarter, with an interest coverage ratio of -12.98, meaning it relies on external financing and could face dilution or liquidity issues. 2) Execution risk — revenue of $113,000 in Q2 2026 is orders of magnitude below the $763.7 million forward estimate, and any delay in project completion or PPA signings would be devastating. 3) Market risk — the stock has a beta not provided but a 68.33% max drawdown, and it has underperformed the S&P 500 by 52.45 percentage points over three months, indicating high volatility and negative momentum. 4) Competitive risk — geothermal faces competition from solar and wind plus storage, which are increasingly cost-competitive, and regulatory changes could reduce subsidies. These risks make FRVO suitable only for speculative investors.
The 12-month forecast has three scenarios: bull case (25% probability) with a target range of $38-$51, assuming successful commercialization and revenue reaching $763.7 million; base case (50% probability) with a target range of $20-$30, assuming slower revenue ramp to $300-500 million and stabilization above the 52-week low; and bear case (25% probability) with a target range of $10-$13.10, assuming project delays and a break below the 52-week low. The base case is most likely, with the key assumption that revenue grows sequentially but at a moderating pace, and the company avoids additional equity raises in 2027. The wide range reflects high uncertainty, and the analyst average target of $38.36 falls within the bull case, suggesting analysts are more optimistic than the base case implies.
FRVO is extremely overvalued on trailing metrics, with a PS ratio of 55,479x and EV/Sales of 7,969.94, compared to the renewable utilities sector average PS of 2-4x. However, on a forward basis, if analysts' revenue estimate of $763.7 million is achieved, the forward PS would be approximately 10x, still a premium but more reasonable. The PB ratio is -31.06 due to negative book value, and the PE is negative, making traditional valuation metrics meaningless. The market is pricing in a near-perfect execution of Fervo's growth strategy, and any disappointment could lead to severe multiple compression. Thus, the stock is overvalued relative to current fundamentals but potentially undervalued if forward estimates are met, creating a binary valuation outcome.
FRVO is a high-risk, high-reward speculative buy only for investors with a strong tolerance for volatility and a long time horizon. The analyst consensus is Strong Buy with an average target of $38.36, implying 179% upside from the current $13.75, but the company generated just $113,000 in Q2 2026 revenue and lost $59.53 million, with a net margin of -510.98%. The biggest downside risk is a break below the 52-week low of $13.10, which could lead to further losses as the company burns $261.22 million in free cash flow per quarter. For those who believe in the geothermal growth story and can stomach a potential 50% drawdown, a small position may be warranted, but it is not suitable for conservative investors or those seeking income.
FRVO is suitable only for long-term investment, with a suggested minimum holding period of 3-5 years, given its pre-revenue status and the time required to commercialize geothermal projects. The company pays no dividend (dividend yield 0%), has a beta not provided but exhibits extreme volatility (68.33% max drawdown), and has limited earnings visibility with only two quarters of public financials. Short-term trading is highly risky due to the stock's 20.24% one-month decline and 49.32% three-month decline, and the short ratio of 2.51 indicates potential for sharp squeezes. Long-term investors should monitor revenue growth, gross margin improvement, and cash burn, and be prepared for significant fluctuations as the company executes its business plan.

